Literature DB >> 17689079

Dual acting antioxidant A1 adenosine receptor agonists.

Alison Gregg1, Steven E Bottle, Shane M Devine, Heidi Figler, Joel Linden, Paul White, Colin W Pouton, Vijay Urmaliya, Peter J Scammells.   

Abstract

Herein we report the synthesis and biological evaluation of some potent and selective A(1) adenosine receptor agonists, which incorporate a functionalised linker attached to an antioxidant moiety. N(6)-(2,2,5,5-Tetramethylpyrrolidin-1-yloxyl-3-ylmethyl)adenosine (VCP28, 2e) proved to be an agonist with high affinity (K(i)=50nM) and good selectivity (A(3)/A(1) > or = 400) for the A(1) adenosine receptor. N(6)-[4-[2-[1,1,3,3-Tetramethylisoindolin-2-yloxyl-5-amido]ethyl]phenyl]adenosine (VCP102, 5a) has higher binding affinity (K(i)=7 nM), but lower selectivity (A(3)/A(1)= approximately 3). All compounds bind weakly (K(i)>1 microM) to A(2A) and A(2B) receptors. The combination of A(1) agonist activity and antioxidant activity has the potential to produce cardioprotective effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689079     DOI: 10.1016/j.bmcl.2007.07.035

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts.

Authors:  Anna Butcher; Peter J Scammells; Paul J White; Shane M Devine; Roselyn B Rose'meyer
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.